PreveCeutical Medical Inc. (CNSX: PREV)
Health Care · Pharmaceuticals · CA
CA$0.02
-25.00% today · -50.0% 1Y
PreveCeutical Medical Inc. (CNSX: PREV) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.71M and employs 5 people.
Over the last twelve months the share price has lost 50.0%, trading between 0.02 and 0.06.
Tweenvest scores PreveCeutical Medical Inc. across four factors: quality 11/100, value 47/100. Its strongest factor is value.
PREV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.71M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- CA$0.06
- 52-week low
- CA$0.02
- Avg volume (3M)
- —
- Shares outstanding
- 638.19M
- Employees
- 5
- Next earnings
- —
About PreveCeutical Medical Inc.
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.
- ISIN
- CA74143C1068
- Listed since
- Jan 11, 2017
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cann Group LimitedASX: CAN | $6.95M | AU$0.01 | +33.33% |
| Traws Pharma, Inc.NasdaqCM: TRAW | $6.84M | $0.42 | -6.78% |
| Epsilon Healthcare LimitedASX: EPN | $6.79M | AU$0.03 | -3.85% |
| Newbury Pharmaceuticals AB (publ)OM: NEWBRY | $6.72M | Skr2.20 | -0.45% |
| Cian Healthcare LimitedBSE: 542678 | $6.70M | Rs25.95 | +6.00% |
| Reviva Pharmaceuticals Holdings, Inc.OTCPK: RVPH | $6.56M | $0.50 | +1.02% |
| Enveric Biosciences, Inc.NasdaqCM: ENVB | $6.49M | $1.47 | +1.38% |
| Phaarmasia LimitedBSE: 523620 | $6.49M | Rs92.00 | -0.43% |
Figures last refreshed Oct 11, 2026.